Triducive

Executive Summary

Triducive is a UK-based digital health company that specializes in generating consensus-led evidence to support healthcare decision-making. Founded in 2017 and headquartered in London, the company employs structured consensus methods, primarily the Delphi Method, to facilitate expert panels and produce peer-reviewed publications. Their work aims to clarify clinical practices, inform policy, and support the adoption of new therapies and technologies. By providing evidence-based consensus from experts, Triducive bridges gaps in clinical knowledge and helps healthcare stakeholders make informed decisions. The company operates at the intersection of digital health and AI/machine learning, though its core offering is methodology-driven rather than technology-heavy. Despite limited publicly available financial or operational data, Triducive's focus on evidence generation positions it as a niche player in the healthcare advisory space, with potential for growth as healthcare systems increasingly rely on structured expert input for policy and practice.

Upcoming Catalysts (preview)

• Q3 2026Publication of new Delphi consensus study in a high-impact journal65% success
• Q4 2026Partnership with a major pharmaceutical or medtech company for therapy adoption support40% success